The Nikkei is the main stock index for the Tokyo Stock Exchange, Japan, comprising the 225 largest Japanese companies. It once again demonstrated its dependence on the development of the US economy, as well as on virus concerns.

For many Japanese enterprises, export revenue accounts for a large share of the overall net worth. Naturally, the United States is one of the main importers. Therefore, almost any positive data from the US often triggers an increase in shares of companies belonging to various segments of Japan's economy. The growth of the Dow Jones index, as well as the upbeat PMI results from IHS Markit, sent the Nikkei 225 higher at the end of last week and Monday, May 24.

Additionally, measures aimed at easing the coronavirus spread also calm down investors, albeit relatively. As the two prefectures began vaccinating members of the armed forces, the sentiment in the Japanese stock market improved considerably. On Monday, the Nikkei 225 index reached 28,364. 61 at the end of trading. Kawasaki Kisen Kaisha Ltd added 7.6% and Nippon Yusen KK grew by 5.6%.

However, the coronavirus pandemic continues to bring uncertainty to the market, especially in Japan. On top of that, the positive trends of recent days do not seem to be strong enough to cause further global growth in Japanese stocks as institutional investors were still cautious to open long traders compared to private ones. When assessing the future prospects of the Nikkei 225, it is recommended to pay attention to the movements of the index near the historically significant resistance level of 28,440, which was recently the support level.